Pediatric Alliance LLC
$2.1M 26 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
MML US, Inc.
MML US, Inc. reported $2,126,815.84 across General Payments, Research, and Ownership to 2,581 physicians and teaching hospitals across 2,806 transactions.
- $2.1M
- All-tracks total
- 2,806
- Transactions
- 2,581
- Recipients
- +$101.3K
- General Payments vs PY2023
MML US, Inc. reported $2,126,815.84 across all CMS Open Payments tracks (General + Research + Ownership) to 2,581 physicians and teaching hospitals in Program Year 2024 - ranking #436 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $954,737.60, averaging $824.03 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer mml-us-inc MML US, Inc.
$2.1M · #436/1,925 · 0.0% industry · PY2024
- TOT $2.1M
- RANK #436
- SHARE 0.0%
- TXN 2,806
- RCP 2,581
- CAT 4
- GEN $954.7K
- ΔGEN +$101.3K
- TOP1 23.6%
- PY 2024
Volume peers
Nearest volume peer: Pediatric Alliance LLC ($2.1M)
MML US, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
MML US, Inc.'s CMS-reported General Payments increased by $101.3K (+11.9%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: MML US, INC.PY2023: MML US, INC.PY2024: MML US, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $853,437.63
- PY2024
- $954,737.60
What the Data Shows for MML US, Inc.
In Program Year 2024, MML US, Inc. reported $2,126,815.84 in payments to 2,581 physicians and teaching hospitals across 2,806 individual transactions, an average of $757.95 per transaction and $824.03 per recipient. That total places MML US, Inc. at rank #436 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
Of the 4 general-payment categories charted below, "Compensation for Services Other Than Consulting" is the largest at $405.3K across 104 transactions, 42.5% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 4 types of general payments, MML US, Inc.'s largest category was "Compensation for Services Other Than Consulting" at $405.3K - 42.5% of General Payments.
MML US, Inc. reports 4 general-payment categories - the top three are Compensation for Services Other Than Consulting (42.5%), Consulting Fee (24.1%), and Travel and Lodging (17.3%). The remaining 1 category make up 16.2% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How MML US, Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $405.3K | 104 | 42.5% |
| Consulting Fee | $229.7K | 43 | 24.1% |
| Travel and Lodging | $165.5K | 241 | 17.3% |
| Food and Beverage | $154.2K | 2,193 | 16.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $552,293.93 (57.8%) of $954,737.60 in this company's General Payments records across 661 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for MML US, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Christopher Gilligan
$225,044.44 across 46 reported transactions
- 2
Frank Schwab
$182,765.26 across 26 reported transactions
- 3
Meredith Langhorst
$57,625.17 across 69 reported transactions
- 4
Robert Heros
$48,065.84 across 56 reported transactions
- 5
Kiran Patel
$38,793.22 across 29 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as MML US, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about MML US, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with MML US, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Mentor Worldwide LLC
$2.1M 8,503 recipients
Compare payment profiles
Coherus Biosciences Inc.
$2.2M 2,945 recipients
Compare payment profiles
ClearPoint Neuro, Inc.
$2.1M 467 recipients
Compare payment profiles
Miach Orthopaedics, Inc.
$2.1M 1,054 recipients
Compare payment profiles
Akebia Therapeutics Inc
$2.2M 5,560 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.